[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-572169-105":53,"doc-detail-572169-en":120},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":113,"head_meta":115,"extra_data":117,"updated_unix":119},105,"en","peptide-therapy-catalog-january-2020","Peptide Therapy Catalog - January 2020","","Peptide Therapy Catalog - January 2020 outlines selected peptide options AOD-9604, BPC-157, and Bremelanotide (PT-141), listing potential benefits, brief scientific summaries, common formulas/protocols, and clinical references. The catalog describes AOD-9604’s fat metabolism support and OA-related cartilage/bone repair effects, BPC-157’s wound and tissue repair and gastro-intestinal support potential, and PT-141’s role in sexual dysfunction and libido-related outcomes. It also provides example dosing regimens and cites published studies.",{"@graph":63,"@context":112},[64,80,95],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/peptide-therapy-catalog-january-2020/572169/",4,{"url":78,"name":59,"@type":81,"author":82,"headline":59,"publisher":85,"fileFormat":88,"inLanguage":57,"description":61,"dateModified":89,"datePublished":89,"encodingFormat":88,"isAccessibleForFree":90,"interactionStatistic":91},"DigitalDocument",{"name":83,"@type":84},"Liam","Person",{"url":68,"name":86,"@type":87},"DocShare","Organization","application/pdf","2026-10-13",true,{"@type":92,"interactionType":93,"userInteractionCount":4},"InteractionCounter",{"@type":94},"ViewAction",{"@type":96,"mainEntity":97},"FAQPage",[98,104,108],{"name":99,"@type":100,"acceptedAnswer":101},"What benefits are listed for AOD-9604 peptide therapy?","Question",{"text":102,"@type":103},"AOD-9604 is presented as supporting lipolysis and fat release, promoting metabolism, and having potential uses in osteoarthritis and related bone/cartilage repair, including when combined with BPC-157.","Answer",{"name":105,"@type":100,"acceptedAnswer":106},"What is the brief overview of BPC-157 included in the catalog?",{"text":107,"@type":103},"BPC-157 is described as a 15-amino-acid partial sequence from body protection compound (BPC) isolated from human gastric juice, with experimental findings focused on accelerating healing across multiple tissue types.",{"name":109,"@type":100,"acceptedAnswer":110},"How is Bremelanotide (PT-141) positioned for use in the catalog?",{"text":111,"@type":103},"PT-141 is described as a synthetic peptide used for erectile dysfunction in men and HSDD in women, with common dosing instructions provided as injections for males/females and a nasal spray schedule prior to sexual activity.","https://schema.org",{"og:url":78,"og:type":114,"og:title":59,"og:site_name":86,"og:description":61},"article",{"robots":116,"canonical":78},"index,follow",{"doc_id":118,"site_id":56},572169,1791925905,{"code":4,"msg":5,"data":121},{"doc_id":118,"user_id":122,"nickname":83,"user_avatar":123,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":124,"file_id":125,"file_url":126,"file_type":127,"file_size":128,"view_count":4,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":35,"language":129,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":130,"faqs":131,"seo_title":132,"seo_description":61,"update_tm":119,"read_time":133},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","| PEPTIDE THERAPY C A T A L O G\u003Cbr>\u003Cbr>\u003Cbr>JANUARY 2020 |\n| --- |\n| [lifemedinstitute.com | 15 W Aylesbury Rd](lifemedinstitute.com | 15 W Aylesbury Rd), Lutherville-Timonium, MD 21093 | 410 .575.1200 |\n\n\n| \u003Cbr>AOD-9604 PEPTIDE THERAPY\u003Cbr>\u003Cbr>BENEFITS MAY INCLUDE\u003Cbr>• Promotes lipolysis without effecting blood sugar or tissue growth\u003Cbr>• Prompts fat release from obese fat cells\u003Cbr>• Prevents lipogenisis (fat accumulation)\u003Cbr>• Treatment in osteoarthritis, hypercholesterolemia, bone and cartilage repair-results favored when combined with BPC-157\u003Cbr>• Boosts the body’s metabolism\u003Cbr>• Less appetite stimulation\u003Cbr>\u003Cbr>BRIEF OVERVIEW\u003Cbr>AOD9604 (Advanced Obesity Drug) is a synthetic peptide fragment that comprises a modified 15 amino acid region of GH with a tyrosine component to help stabilize the molecule. It was originally developed by Professor Frank Ng at Monash University in Australia, with the intent of finding an anti-obesity drug that had the fat burning effects of human growth hormone (HGH) without the muscle-building effect. Similar to GH, AOD9604 aids weight reduction in rodent models of obesity and was originally developed for the treatment of obesity in humans. Additionally, it does not stimulate the production of IGF-1, has positive effects on the differentiation of adipose mesenchymal stem cells into bone, and was found to promote proteoglycan and collagen production in isolated bovine chondrocytes in an in vitro study. Its positive effects include promoting the repair of bone and cartilage in cases of OA.\u003Cbr>COMMON FORMULAS & PROTOCOLS\u003Cbr>AOD 9604 (6mg) Lyophilized Vial-300mcg SQ injection daily for 20 days\u003Cbr>CLINICAL REFERENCES\u003Cbr>1. Heffernan M, et al.“The Effects of Human GH and Its Lipolytic Fragment (AOD9604) on Lipid Metabolism Following Chronic Treatment in Obese Mice andβ 3-AR Knock-Out Mice”\u003Cbr>2. Stier H, et al.“Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans” Journal of Endocrinology and Metabolism, North America (2013)\u003Cbr>Additional references available. Contact us for more info.\u003Cbr>|\n| --- |\n| [lifemedinstitute.com | 15 W Aylesbury Rd](lifemedinstitute.com | 15 W Aylesbury Rd), Lutherville-Timonium, MD 21093 | 410 .575.1200 |\n\n\n| \u003Cbr>BPC-157 PEPTIDE THERAPY\u003Cbr>BENEFITS MAY INCLUDE\u003Cbr>• Supports cognitive performance\u003Cbr>• Supports joint health\u003Cbr>• Protects against drug-induced damage\u003Cbr>• Restores the serotogenic transport system\u003Cbr>• Protects dopaminergic system\u003Cbr>• Enhances the GABAergic system\u003Cbr>• Reverse opioid tolerance\u003Cbr>• Accelerated wound healing\u003Cbr>• Ligament healing (knee, rotary)\u003Cbr>• Benefits for ulcers in the stomach\u003Cbr>• Benefits for intestinal damage\u003Cbr>• May help irritable bowel disease\u003Cbr>• Promotes lipolysis\u003Cbr>• Improves overall skin appearance\u003Cbr>• Repairs skin barrier proteins\u003Cbr>BRIEF OVERVIEW\u003Cbr>\u003Cbr>BPC 157, composed of 15 amino acids, is a partial sequence of body protection compound (BPC) that is discovered in and isolated from human gastric juice. Experimentally it has been demonstrated to accelerate the healing of many different wounds, including tendons, muscles, nervous system and superior healing of damaged ligaments. Those who suffer from discomfort due to muscle sprains, tears and damage may benefit from treatment with this peptide. It can also help aid skin burns to heal at a faster rate and increase blood flow to damaged tissues.\u003Cbr>COMMON FORMULAS & PROTOCOLS\u003Cbr>BPC-157 (10mg) Lyophilized Vial-300mcg SQ injection nightly for 30 days BPC-157 (500mcg) Capsule-One capsule daily for 30 days\u003Cbr>CLINICAL REFERENCES\u003Cbr>1. Cerovecki, Tomislav; Bojanic, Ivan; Brcic, Luka; Radic, Bozo; Vukoja, Ivan; Seiwerth, Sven; Sikiric, Predrag (September 2010) .\u003Cbr>\"Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat\". Journal of Orthopaedic Research. 28 (9): 1155– 1161. doi:10.1002/jor.21107 . ISSN 1554-527X. PMID 20225319.\u003Cbr>2. \"Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Cr","cbCailMJ3iL1PDQY","https://ap.wps.com/l/cbCailMJ3iL1PDQY","pdf",9225389,"English","# AOD-9604 PEPTIDE THERAPY\n## Benefits may include\n## Brief overview\n## Common formulas & protocols\n## Clinical references\n# BPC-157 PEPTIDE THERAPY\n## Benefits may include\n## Brief overview\n## Common formulas & protocols\n## Clinical references\n# BREMELANOTIDE (PT-141) PEPTIDE THERAPY\n## Benefits may include\n## Brief overview\n## Common formulas & protocols\n## Clinical references","[{\"question\":\"What benefits are listed for AOD-9604 peptide therapy?\",\"answer\":\"AOD-9604 is presented as supporting lipolysis and fat release, promoting metabolism, and having potential uses in osteoarthritis and related bone/cartilage repair, including when combined with BPC-157.\"},{\"question\":\"What is the brief overview of BPC-157 included in the catalog?\",\"answer\":\"BPC-157 is described as a 15-amino-acid partial sequence from body protection compound (BPC) isolated from human gastric juice, with experimental findings focused on accelerating healing across multiple tissue types.\"},{\"question\":\"How is Bremelanotide (PT-141) positioned for use in the catalog?\",\"answer\":\"PT-141 is described as a synthetic peptide used for erectile dysfunction in men and HSDD in women, with common dosing instructions provided as injections for males/females and a nasal spray schedule prior to sexual activity.\"}]","Peptide Therapy Catalog - January 2020 | PDF",6]